NasdaqGS - Nasdaq Real Time Price USD

Stoke Therapeutics, Inc. (STOK)

Compare
12.06 -0.26 (-2.11%)
At close: December 13 at 4:00:01 PM EST
12.29 +0.23 (+1.91%)
After hours: December 13 at 5:00:19 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
16,743.00
8,780.00
12,405.00
--
--
Operating Expense
134,048.00
123,553.00
116,761.00
86,065.00
53,044.00
Operating Income
-117,305.00
-114,773.00
-104,356.00
-86,065.00
-53,044.00
Net Non Operating Interest Income Expense
12,255.00
9,908.00
3,122.00
120.00
700.00
Other Income Expense
-407.00
166.00
167.00
140.00
101.00
Pretax Income
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Net Income Common Stockholders
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Diluted NI Available to Com Stockholders
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Basic EPS
-2.08
-2.38
-2.60
-2.34
-1.56
Diluted EPS
-2.08
-2.38
-2.60
-2.34
-1.56
Basic Average Shares
50,985.63
43,994.86
38,897.44
36,739.27
33,488.46
Diluted Average Shares
50,985.63
43,994.86
38,897.44
36,739.27
33,488.46
Total Operating Income as Reported
-117,305.00
-114,773.00
-104,356.00
-86,065.00
-53,044.00
Total Expenses
134,048.00
123,553.00
116,761.00
86,065.00
53,044.00
Net Income from Continuing & Discontinued Operation
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Normalized Income
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Interest Income
--
--
--
120.00
744.00
Net Interest Income
12,255.00
9,908.00
3,122.00
120.00
700.00
EBIT
-117,305.00
-114,773.00
-104,356.00
-86,065.00
-53,044.00
EBITDA
-115,030.00
-112,304.00
-102,810.00
-85,091.00
-52,156.00
Reconciled Depreciation
2,275.00
2,469.00
1,546.00
974.00
888.00
Net Income from Continuing Operation Net Minority Interest
-105,457.00
-104,699.00
-101,067.00
-85,805.00
-52,243.00
Normalized EBITDA
-115,030.00
-112,304.00
-102,810.00
-85,091.00
-52,156.00
12/31/2020 - 6/19/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AKRO Akero Therapeutics, Inc.
28.89
-0.48%
 
CRNX Crinetics Pharmaceuticals, Inc.
53.66
-3.52%
 
NRIX Nurix Therapeutics, Inc.
20.27
-1.41%
 
ALEC Alector, Inc.
1.9700
-3.43%
 
ACLX Arcellx, Inc.
83.80
+0.46%
 
ANAB AnaptysBio, Inc.
15.59
+3.79%
 
SLRN Acelyrin, Inc.
3.2300
-8.76%
 
PTGX Protagonist Therapeutics, Inc.
41.08
+1.73%
 
BCYC Bicycle Therapeutics plc
13.81
-31.33%
 
OKUR OnKure Therapeutics, Inc.
9.86
-8.96%